In every war there is a constant contest of upgrades between the combatants. Nature is a tenacious and resourceful adversary. It isn’t two weeks to anything.
(Reuters) – AstraZeneca denied on Monday its COVID-19 vaccine is not very effective for people over 65, after German media reports said officials fear the vaccine may not be approved in the European Union for use in the elderly.
German daily papers Handelsblatt and Bild said in separate reports the vaccine – co-developed by AstraZeneca and Oxford University – had an efficacy of 8% or less than 10%, respectively, in those over 65. …
In a written response, AstraZeneca described the German media reports saying its COVID-19 vaccine was shown to have a very low efficacy in the elderly as “completely incorrect”.
Moderna Inc. MRNA 12.20% said its Covid-19 vaccine appeared to protect against emerging variants of the coronavirus in laboratory tests, but as a precaution it would test whether a booster shot improves immune responses and develop a new vaccine targeting the strain first identified in South Africa.